US approves world's first RSV vaccine

Pallade Veneta - US approves world's first RSV vaccine

HEALTH 03.05.2023

US approves world's first RSV vaccine / Photo: JEAN-FRANCOIS MONIER - AFP

The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly.

Change text size:

It marks the first such approval globally, with similar vaccines from other makers including Pfizer expected to follow soon.

"Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening," said senior US Food and Drug Administration (FDA) official Peter Marks in a statement.

RSV normally causes mild, cold-like symptoms, but can be serious for people with weak immune systems.

According to the US Centers for Disease Control and Prevention, it leads to approximately 60,000 to 120,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 years of age and older.

The vaccine was approved for people aged 60 and older, based on a study of 25,000 people that showed a single dose was 83 percent effective against disease caused by RSV, and more than 94 percent effective against severe disease.

The most common side effects included injection site pain, fatigue, muscle pain, headache and joint stiffness.

An irregular heartbeat was a less common side effect, occurring in 10 participants who received Arexy and 4 participants who received placebo.

GSK's Arexy has been recommended for approval by the European Union's drug watchdog, the European Medicines Agency, whose positive opinions are normally formally followed by the European Commission.

Pfizer has said that it expects a decision from the FDA in May for its own over-60s RSV vaccine.

In January, Moderna said it hopes its RSV vaccine would be approved and available for the Northern Hemisphere's winter later this year.

Last year, the EU approved a preventative antibody treatment against RSV, developed by British-Swedish pharmaceutical firm AstraZeneca and France's Sanofi.

F.Amato--PV

Seacliff Healthcare Seeks Specialist GP in Thirroul

Seacliff Healthcare, located in the Illawarra region of New South Wales, is seeking a Specialist General Practitioner to join its team. The practice, situated near Thirroul village station, currently supports five GPs and has capacity for additional medical staff with onsite pathology and allied health services.

India proposes more import entry points for drugs and medical devices

New Delhi The Union Health Ministry has proposed expanding the network of authorised import gateways for drugs, medical devices and cosmetics by adding several inland container depots, a special economic zone and an international airport to facilitate faster clearance and improve supply chain efficiency. The proposed amendment to Rule 43A of the Drugs Rules, 1945, seeks to include additional entry points in Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka, as reported by a gazette notification issued by the

Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise

Grace Griffin thought she had calculated her pregnancy expenses accurately until bills exceeded $9,000—more than triple her insurer’s estimate. Her experience highlights a systemic failure in healthcare transparency, as federal rules designed to provide accurate cost predictions remain unimplemented. With maternity billing codes set to change next year, experts urge parents to master insurance details and verify every bill.

Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya

KUWAIT: The Public Authority for Food and Nutrition (PAFN) issued nine violation reports and destroyed 115 kilograms of meat of unknown origin during an inspection tour of food establishments in Farwaniya Governorate, the authority announced on Monday. The tour was carried out by the authority’s Farwaniya food inspection department.